As of 2025-07-05, the Relative Valuation of Revive Therapeutics Ltd (RVV.CN) is 0.02 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.02 CAD, the upside of Revive Therapeutics Ltd based on Relative Valuation is 0.3%.
The range of the Relative Valuation is 0.02 - 0.02 CAD.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | -2.1x - -2.1x | -2.1x |
| Fair Price | 0.02 - 0.02 | 0.02 |
| Upside | 0.3% - 0.3% | 0.3% |
| Date | P/E |
| 2025-07-02 | -2.09 |
| 2025-06-30 | -2.09 |
| 2025-06-27 | -2.09 |
| 2025-06-26 | -2.09 |
| 2025-06-25 | -2.09 |
| 2025-06-24 | -2.09 |
| 2025-06-23 | -2.09 |
| 2025-06-20 | -2.62 |
| 2025-06-19 | -2.09 |
| 2025-06-18 | -2.09 |
| 2025-06-17 | -2.09 |
| 2025-06-16 | -2.62 |
| 2025-06-13 | -2.62 |
| 2025-06-12 | -2.09 |
| 2025-06-11 | -2.62 |
| 2025-06-10 | -3.14 |
| 2025-06-09 | -3.66 |
| 2025-06-06 | -3.14 |
| 2025-06-05 | -2.62 |
| 2025-06-04 | -3.14 |
| 2025-06-03 | -3.14 |
| 2025-06-02 | -3.14 |
| 2025-05-30 | -3.14 |
| 2025-05-29 | -2.62 |
| 2025-05-28 | -2.62 |
| 2025-05-27 | -3.14 |
| 2025-05-26 | -2.62 |
| 2025-05-23 | -3.14 |
| 2025-05-22 | -2.62 |
| 2025-05-21 | -2.62 |
| 2025-05-20 | -2.62 |
| 2025-05-16 | -2.62 |
| 2025-05-15 | -2.62 |
| 2025-05-14 | -2.62 |
| 2025-05-13 | -2.62 |
| 2025-05-12 | -3.14 |
| 2025-05-09 | -3.14 |
| 2025-05-08 | -2.62 |
| 2025-05-06 | -3.14 |
| 2025-05-05 | -2.62 |
| 2025-05-02 | -2.62 |
| 2025-05-01 | -3.14 |
| 2025-04-30 | -3.14 |
| 2025-04-29 | -3.14 |
| 2025-04-28 | -3.14 |
| 2025-04-25 | -2.62 |
| 2025-04-24 | -3.14 |
| 2025-04-23 | -3.14 |
| 2025-04-22 | -3.14 |
| 2025-04-21 | -3.14 |